Loading...
XASXNAN
Market cap577mUSD
Dec 23, Last price  
3.05AUD
1D
1.67%
1Q
-13.11%
Jan 2017
-1.93%
IPO
296.10%
Name

Nanosonics Ltd

Chart & Performance

D1W1MN
XASX:NAN chart
P/E
71.37
P/S
5.40
EPS
0.04
Div Yield, %
0.00%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
15.26%
Revenues
172m
+2.42%
8,4240309,000763,0002,247,00012,301,00014,899,00021,492,00022,214,00042,796,00067,507,00060,698,00084,324,00099,382,000101,834,000119,728,000167,515,000171,561,000
Net income
13m
-34.76%
-5,703,524-7,147,000-8,754,000-8,172,000-11,214,000-4,679,000-5,768,000-2,605,000-5,460,000122,00026,158,0005,751,00013,602,00010,137,0008,578,0003,742,00019,883,00012,972,000
CFO
23m
-2.28%
-4,586,396-7,135,000-9,136,000-7,762,000-9,001,000-5,029,000-4,506,000-2,594,000-2,421,0003,224,00016,388,0009,009,0004,826,00022,764,0007,315,0006,695,00023,314,00022,782,000
Earnings
Feb 24, 2025

Profile

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
URL
https://www.nanosonics.com.au/
IPO date
May 17, 2007
Employees
482
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
171,561
2.42%
167,515
39.91%
119,728
17.57%
Cost of revenue
163,175
153,691
123,085
Unusual Expense (Income)
NOPBT
8,386
13,824
(3,357)
NOPBT Margin
4.89%
8.25%
Operating Taxes
14
1,713
(2,164)
Tax Rate
0.17%
12.39%
NOPAT
8,372
12,111
(1,193)
Net income
12,972
-34.76%
19,883
431.35%
3,742
-56.38%
Dividends
Dividend yield
Proceeds from repurchase of equity
334
356
316
BB yield
-0.04%
-0.02%
-0.03%
Debt
Debt current
3,141
2,882
2,554
Long-term debt
15,465
15,676
18,316
Deferred revenue
16,028
13,913
9,665
Other long-term liabilities
722
1,277
1,000
Net debt
(111,882)
(94,442)
(73,643)
Cash flow
Cash from operating activities
22,782
23,314
6,695
CAPEX
(2,517)
(3,571)
(6,966)
Cash from investing activities
(2,364)
(3,541)
(6,902)
Cash from financing activities
(3,006)
(2,712)
(1,973)
FCF
11,751
655
(16,276)
Balance
Cash
129,552
112,159
94,512
Long term investments
936
841
1,000
Excess cash
121,910
104,624
88,527
Stockholders' equity
182,202
163,860
138,691
Invested Capital
86,345
85,146
71,783
ROIC
9.76%
15.43%
ROCE
4.03%
7.06%
EV
Common stock shares outstanding
308,882
306,293
305,604
Price
2.99
-36.92%
4.74
41.07%
3.36
-42.76%
Market cap
923,556
-36.39%
1,451,827
41.39%
1,026,829
-42.68%
EV
811,674
1,357,385
953,186
EBITDA
16,018
20,960
2,370
EV/EBITDA
50.67
64.76
402.19
Interest
1,105
771
557
Interest/NOPBT
13.18%
5.58%